Financial reports
10-K
2023 FY
Annual report
26 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
10-Q
2023 Q1
Quarterly report
5 May 23
10-K/A
2022 FY
Annual report (amended)
28 Mar 23
10-K
2022 FY
Annual report
27 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
10-Q
2022 Q1
Quarterly report
11 May 22
10-K
2021 FY
Annual report
25 Mar 22
Current reports
8-K
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2024
25 Apr 24
8-K
UTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance
30 Jan 24
8-K
Utah Medical Products, Inc. Increases Regular Quarterly Dividend
31 Oct 23
8-K
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2023
26 Oct 23
8-K
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2023
25 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
8 May 23
8-K
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2023
25 Apr 23
8-K
UTMD Reports Audited Year 2022 and Fourth Quarter Financial Performance
31 Jan 23
8-K
Other Events
1 Nov 22
8-K
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022
25 Oct 22
Registration and prospectus
S-8
Registration of securities for employees
14 Jul 23
S-8
Registration of securities for employees
15 Oct 14
S-3/A
Shelf registration (amended)
13 Nov 12
S-3/A
Shelf registration (amended)
25 Oct 12
S-3/A
Shelf registration (amended)
10 Sep 12
S-3
Shelf registration
12 Jun 12
RW
Registration withdrawal request
2 Feb 12
S-3
Shelf registration
8 Sep 08
S-8
Registration of securities for employees
30 Aug 05
SC TO-I/A
Issuer tender offer statement (amended)
15 Nov 02
Proxies
DEFA14A
Additional proxy soliciting materials
15 Apr 24
DEF 14A
Definitive proxy
9 Apr 24
DEFA14A
Additional proxy soliciting materials
12 Apr 23
DEF 14A
Definitive proxy
4 Apr 23
DEF 14A
Definitive proxy
13 Apr 22
DEF 14A
Definitive proxy
9 Apr 21
DEF 14A
Definitive proxy
14 Jul 20
DEF 14A
Definitive proxy
5 Apr 19
PX14A6G
Letter to shareholders
9 Apr 18
DEF 14A
Definitive proxy
8 Mar 18
Other
SD
Conflict minerals disclosure
30 May 23
SD
Conflict minerals disclosure
31 May 22
SD
Conflict minerals disclosure
26 May 21
SD
Conflict minerals disclosure
29 May 20
UPLOAD
Letter from SEC
13 Sep 19
CORRESP
Correspondence with SEC
10 Sep 19
UPLOAD
Letter from SEC
10 Sep 19
SD
Conflict minerals disclosure
31 May 19
SD
Conflict minerals disclosure
31 May 18
SD
Conflict minerals disclosure
31 May 17
Ownership
SC 13G/A
T. Rowe Price Investment Management, Inc.
14 Feb 24
SC 13G/A
RENAISSANCE TECHNOLOGIES LLC
13 Feb 24
SC 13G/A
FMR LLC
9 Feb 24
SC 13G/A
BlackRock Inc.
29 Jan 24
4
Brian Koopman
26 Dec 23
4
Brian Koopman
20 Jun 23
144
Notice of proposed sale of securities
14 Jun 23
4
PAUL O RICHINS
19 May 23
144
Notice of proposed sale of securities
18 May 23
4
PAUL O RICHINS
17 Mar 23